These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38924383)

  • 1. Overexpression of macrophage migration inhibitory factor protects against pressure overload-induced cardiac hypertrophy through regulating the miR-29b-3p/HBP1 axis.
    Wen L; Chen W; Zhu C; Li J; Zhou J; Zhang M; Zhang W; Xue Q
    Physiol Rep; 2024 Jun; 12(12):e16022. PubMed ID: 38924383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Smad3-miR-29b/miR-29c axis mediates the protective effect of macrophage migration inhibitory factor against cardiac fibrosis.
    Liang JN; Zou X; Fang XH; Xu JD; Xiao Z; Zhu JN; Li H; Yang J; Zeng N; Yuan SJ; Pan R; Fu YH; Zhang M; Luo JF; Wang S; Shan ZX
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2441-2450. PubMed ID: 31175931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
    Koga K; Kenessey A; Ojamaa K
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H282-93. PubMed ID: 23144312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p.
    Xu X; Wang J; Wang X
    Drug Des Devel Ther; 2020; 14():5699-5710. PubMed ID: 33402817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
    Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
    J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA-NEAT1 from the competing endogenous RNA network promotes cardioprotective efficacy of mesenchymal stem cell-derived exosomes induced by macrophage migration inhibitory factor via the miR-142-3p/FOXO1 signaling pathway.
    Chen H; Xia W; Hou M
    Stem Cell Res Ther; 2020 Jan; 11(1):31. PubMed ID: 31964409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_nuclear factor I X (circNfix) attenuates pressure overload-induced cardiac hypertrophy via regulating miR-145-5p/ATF3 axis.
    Pan J; Xu Z; Guo G; Xu C; Song Z; Li K; Zhong K; Wang D
    Bioengineered; 2021 Dec; 12(1):5373-5385. PubMed ID: 34468254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.
    Zhuang L; Xia W; Chen D; Ye Y; Hu T; Li S; Hou M
    J Nanobiotechnology; 2020 Oct; 18(1):157. PubMed ID: 33129330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p.
    Zhu W; Sun L; Zhao P; Liu Y; Zhang J; Zhang Y; Hong Y; Zhu Y; Lu Y; Zhao W; Chen X; Zhang F
    J Nanobiotechnology; 2021 Feb; 19(1):61. PubMed ID: 33639970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p.
    Ni H; Li W; Zhuge Y; Xu S; Wang Y; Chen Y; Shen G; Wang F
    Int J Cardiol; 2019 Oct; 292():188-196. PubMed ID: 30967276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
    Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
    PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy.
    Xu X; Hua Y; Nair S; Bucala R; Ren J
    Hypertension; 2014 Mar; 63(3):490-9. PubMed ID: 24366076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice.
    Song C; Qi H; Liu Y; Chen Y; Shi P; Zhang S; Ren J; Wang L; Cao Y; Sun H
    Mol Ther; 2021 Mar; 29(3):1120-1137. PubMed ID: 33130312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure.
    Zhang L; Liu M; Jiang H; Yu Y; Yu P; Tong R; Wu J; Zhang S; Yao K; Zou Y; Ge J
    J Cell Mol Med; 2016 Mar; 20(3):459-70. PubMed ID: 26647902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.
    Li G; Shao Y; Guo HC; Zhi Y; Qiao B; Ma K; Du J; Lai YQ; Li Y
    Cardiovasc Res; 2022 Jul; 118(9):2139-2151. PubMed ID: 34358309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p.
    Zou X; Wang J; Tang L; Wen Q
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):482-490. PubMed ID: 31183682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice.
    Lee KN; Lu X; Nguyen C; Feng Q; Chidiac P
    J Mol Cell Cardiol; 2017 Jul; 108():194-202. PubMed ID: 28641980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.